Research Synopsis: In 2015, hidradenitis suppurativa (HS) was deemed a rare disease that was reported to affect fewer than 200 000 adults in the US, thus allowing adalimumab (Humira; AbbVie) […]
Subject: Pediatric
Differences Between Children & Adults with HS
Research Synopsis: This cohort study suggests that pediatric patients utilize high-cost ED care when HS can often be treated as an outpatient. These data suggest that there are opportunities […]
Pediatric Endoscopic Treatment
Pediatric Endoscopic Hidradenitis Treatment: A New Minimally Invasive Treatment for Pediatric Patients with HS Note: Pediatric HS is not ‘infrequent,’ just incredibly misdiagnosed and under-reported. Synopsis: Background: Hidradenitis […]